logo

For the Inventor, By the Inventor

Tutzing, Germany

Hans Seidel

This inventor holds 19 USPTO granted patents, primarily in Biochemical Analysis. Top assignee: Boehringer Mannheim Gmbh. Active years: 1980-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Seidel. Retrieved from https://idiyas.com/inventor/hans-seidel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 121(Granted Patents)


Company Filing History:

goldMedal19 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents

Years Active: 1980-1995

Loading Chart...
Areas of Expertise:
Thiazoloisoindolinone
Antiviral Medicaments
Sarcosine Oxidase
Cholesterol Esterase
Pyruvate Oxidase
Glycerin Determination
NAD(P)H
Biochemical Reagents
Glycerol Dehydrogenase
Enzyme Production
Cholesterol Determination
Maltose Phosphorylase
19 patents (USPTO):Explore Patents
1. 5397794 - Use of thiazoloisoindolinone derivatives as antiviral medicaments (1995-03-14),
2. 5024945 - Process for obtaining sarcosine oxidase from microorganisms (1991-06-18),
3. 4845029 - Method for the determination of sarcosine creatine or creatinine (1989-07-04),
4. 4760077 - Pyrrothine derivatives and pharmaceutical use thereof (1988-07-26),
5. 4743549 - Hydrogen peroxide-forming sarcosine oxidase (1988-05-10),
6. 4666832 - Pyruvate oxidase (1987-05-19),
7. 4615981 - Process for obtaining cholesterol esterase from microorganisms (1986-10-07),
8. 4550079 - Determination of L(+)-tartrate or D(+)-malate with L(+)-tartrate (1985-10-29),
9. 4416983 - Determination of NAD(P)H or salicylate (1983-11-22),
10. 4399218 - Method and reagent for the determination of glycerin (1983-08-16),
11. 4397952 - Process for obtaining glucose dehydrogenase and micro-organism therefor (1983-08-09),
12. 4395489 - Process for the recovery of glycerol dehydrogenase (1983-07-26),
13. 4383032 - Reagent for the determination of .beta.-lactamase (1983-05-10),
14. 4360596 - Process for the preparation of cholesterol esterase (1982-11-23),
15. 4343903 - Process for obtaining cholesterol esterase from micro-organisms (1982-08-10),

Title: Innovations in Antiviral Medicaments: The Patents of Hans Seidel

Introduction

Hans Seidel, an accomplished inventor based in Tutzing, Germany, has an impressive portfolio of 19 patents. His work focuses on advancements in medicinal chemistry, particularly in the field of antiviral treatments. Seidel's contributions demonstrate a commitment to innovative solutions that address public health challenges.

Latest Patents

Among his latest patents, Seidel has made significant strides with the invention titled "Use of thiazoloisoindolinone derivatives as antiviral medicaments." This patent highlights his dedication to finding new therapeutic agents to combat viral infections. Another notable invention is "Process for obtaining sarcosine oxidase from microorganisms." This innovative process involves culturing Pseudomonas strains to extract the enzyme, showcasing his expertise in biotechnology and enzyme production.

Career Highlights

Hans Seidel's career is marked by his tenure at Boehringer Mannheim GmbH, a company renowned for its contributions to healthcare and pharmaceuticals. Over the years, his research has led to numerous patents that not only enhance scientific knowledge but also hold practical applications in medicine.

Collaborations

Throughout his career, Seidel has collaborated with esteemed colleagues, including Helmgard Gauhl and Albert Roder. These partnerships have facilitated the exchange of ideas and fostered an environment of innovation, leading to advancements in their respective fields.

Conclusion

Hans Seidel's work exemplifies the impact of innovative thinking in the realm of pharmaceuticals. With his extensive patent portfolio and collaborative spirit, he continues to push the boundaries of science, contributing to the development of new antiviral treatments that may significantly improve public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…